09Oct 2022
Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: an updated meta‐analysis of randomized controlled trials with external adjudication of events

Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: an updated meta‐analysis of randomized controlled trials with external adjudication of events

To investigate the effects of glucose‐lowering agents on all‐cause mortality and cardiovascular and renal outcomes in adults with type 2 diabetes. In addition, the results of this updated meta‐analysis need to be considered in the choice of drug treatment for T2DM, which cannot be merely based on the effect of glucose‐lowering drugs on long‐term glycemic control.

  • #endo-diabetology

Like

Save

Share